BioSolution Acquires Patent Rights for Exosome Isolation Method
[Asia Economy Reporter Oh Ju-yeon] BioSolution announced on the 22nd that it has acquired a domestic patent for a size-based separation method that highly concentrates extracellular vesicles from fluid samples.
The company stated, "This invention is a method to concentrate and separate exosomes secreted from stem cells at low cost and high efficiency," adding, "Compared to existing exosome separation methods, it offers faster separation speed and higher separation efficiency, providing economic advantages."
Hot Picks Today
!['Still Hesitant? If You're Wondering Whether KOSPI Will Rise, This Is the Number You Must Watch [Weekend Money]'](https://cwcontent.asiae.co.kr/asiaresize/93/2026051415173163355_1778739450.jpg)
'Still Hesitant? If You're Wondering Whether KOSPI Will Rise, This Is the Number You Must Watch [Weekend Money]'
- About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- Is It Really Like an Illness? "I Can't Wait to Go Again"—Over 1 Million Visited in Q1, Now 'Busanbyeong' Takes Hold [K-Holic]
They continued, "This is a valuable patent that can secure rights without restrictions in the application fields of exosome-based therapies as a foundational technology for exosome-based therapeutics," and "We plan to utilize it in the development of treatments for intractable diseases using stem cell, immune cell, and somatic cell exosomes in the future."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
